| 000 | 01789 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250517032151.0 | ||
| 264 | 0 | _c20160527 | |
| 008 | 201605s 0 0 eng d | ||
| 022 | _a1476-5365 | ||
| 024 | 7 |
_a10.1038/bmt.2015.103 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPulsipher, M A | |
| 245 | 0 | 0 |
_aRisk factors and timing of relapse after allogeneic transplantation in pediatric ALL: for whom and when should interventions be tested? _h[electronic resource] |
| 260 |
_bBone marrow transplantation _cSep 2015 |
||
| 300 |
_a1173-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAllografts |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGraft vs Host Disease _xblood |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNeoplasm, Residual |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xblood |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aLangholz, B | |
| 700 | 1 | _aWall, D A | |
| 700 | 1 | _aSchultz, K R | |
| 700 | 1 | _aBunin, N | |
| 700 | 1 | _aCarroll, W | |
| 700 | 1 | _aRaetz, E | |
| 700 | 1 | _aGardner, S | |
| 700 | 1 | _aGoyal, R K | |
| 700 | 1 | _aGastier-Foster, J | |
| 700 | 1 | _aBorowitz, M | |
| 700 | 1 | _aTeachey, D | |
| 700 | 1 | _aGrupp, S A | |
| 773 | 0 |
_tBone marrow transplantation _gvol. 50 _gno. 9 _gp. 1173-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/bmt.2015.103 _zAvailable from publisher's website |
| 999 |
_c24888646 _d24888646 |
||